Sonnet BioTherapeutics Holdings, Inc. (SONN)
NASDAQ: SONN · IEX Real-Time Price · USD
1.845
+0.055 (3.07%)
Apr 24, 2024, 3:51 PM EDT - Market closed

SONN Statistics

Total Valuation

SONN has a market cap or net worth of $5.66 million. The enterprise value is $2.83 million.

Market Cap 5.66M
Enterprise Value 2.83M

Important Dates

The next estimated earnings date is Wednesday, May 8, 2024, before market open.

Earnings Date May 8, 2024
Ex-Dividend Date n/a

Share Statistics

SONN has 3.07 million shares outstanding. The number of shares has increased by 1,107.66% in one year.

Shares Outstanding 3.07M
Shares Change (YoY) +1,107.66%
Shares Change (QoQ) +265.81%
Owned by Insiders (%) 9.22%
Owned by Institutions (%) 3.53%
Float 2.71M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 43.84
Forward PS 111.04
PB Ratio 2.20
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 21.90
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.74, with a Debt / Equity ratio of 0.07.

Current Ratio 1.74
Quick Ratio n/a
Debt / Equity 0.07
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -519.50% and return on invested capital (ROIC) is -524.04%.

Return on Equity (ROE) -519.50%
Return on Assets (ROA) -169.50%
Return on Capital (ROIC) -524.04%
Revenue Per Employee $10,765
Profits Per Employee -$1.20M
Employee Count 12
Asset Turnover 0.02
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -68.11% in the last 52 weeks. The beta is 1.12, so SONN's price volatility has been higher than the market average.

Beta (1Y) 1.12
52-Week Price Change -68.11%
50-Day Moving Average 1.88
200-Day Moving Average 3.02
Relative Strength Index (RSI) 48.90
Average Volume (30 Days) 104,046

Short Selling Information

The latest short interest is 452,181, so 14.73% of the outstanding shares have been sold short.

Short Interest 452,181
Short Previous Month 557,458
Short % of Shares Out 14.73%
Short % of Float 16.71%
Short Ratio (days to cover) 1.88

Income Statement

In the last 12 months, SONN had revenue of $129,176 and -$14.46 million in losses. Loss per share was -$9.87.

Revenue 129,176
Gross Profit 129,176
Operating Income -14.46M
Pretax Income -14.46M
Net Income -14.46M
EBITDA -14.38M
EBIT -14.46M
Loss Per Share -$9.87
Full Income Statement

Balance Sheet

The company has $3.02 million in cash and $186,686 in debt, giving a net cash position of $2.83 million or $0.92 per share.

Cash & Cash Equivalents 3.02M
Total Debt 186,686
Net Cash 2.83M
Net Cash Per Share $0.92
Equity / Book Value 2.57M
Book Value Per Share 0.84
Working Capital 1.97M
Full Balance Sheet

Cash Flow

Operating Cash Flow -18.52M
Capital Expenditures n/a
Free Cash Flow -18.52M
FCF Per Share -$4.88
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -11,193.33% and -11,193.30%.

Gross Margin 100.00%
Operating Margin -11,193.33%
Pretax Margin -11,193.30%
Profit Margin -11,193.30%
EBITDA Margin -11,133.47%
EBIT Margin -11,193.30%
FCF Margin -14,335.80%

Dividends & Yields

SONN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1,107.66%
Shareholder Yield -1,107.66%
Earnings Yield -255.31%
FCF Yield -326.99%

Analyst Forecast

The average price target for SONN is $61.47, which is 3,231.71% higher than the current price. The consensus rating is "Strong Buy".

Price Target $61.47
Price Target Difference 3,231.71%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on September 1, 2023. It was a reverse split with a ratio of 1:22.

Last Split Date Sep 1, 2023
Split Type Reverse
Split Ratio 1:22

Scores

SONN has an Altman Z-Score of -36.47 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -36.47
Piotroski F-Score 2